Cargando…
Antibody–Drug Conjugates for the Treatment of Acute Pediatric Leukemia
The clinical development of antibody–drug conjugates (ADCs) has gained momentum in recent years and these agents are gradually moving into frontline regimens for pediatric acute leukemias. ADCs consist of a monoclonal antibody attached to a cytotoxic payload by a cleavable linker. This structure all...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396964/ https://www.ncbi.nlm.nih.gov/pubmed/34441852 http://dx.doi.org/10.3390/jcm10163556 |